Kirsten Eibl‐Lindner

480 total citations
23 papers, 391 citations indexed

About

Kirsten Eibl‐Lindner is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Kirsten Eibl‐Lindner has authored 23 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Kirsten Eibl‐Lindner's work include Intraocular Surgery and Lenses (13 papers), Ocular Infections and Treatments (7 papers) and Retinal and Macular Surgery (7 papers). Kirsten Eibl‐Lindner is often cited by papers focused on Intraocular Surgery and Lenses (13 papers), Ocular Infections and Treatments (7 papers) and Retinal and Macular Surgery (7 papers). Kirsten Eibl‐Lindner collaborates with scholars based in Germany, United States and France. Kirsten Eibl‐Lindner's co-authors include Christian Wertheimer, Armin Wolf, Anselm Kampik, Raffael Liegl, Wolfgang J. Mayer, Claudia Priglinger, Jakob Siedlecki, Marcus Kernt, Siegfried Priglinger and Denitsa Docheva and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, European Journal of Pharmaceutics and Biopharmaceutics and Journal of Cataract & Refractive Surgery.

In The Last Decade

Kirsten Eibl‐Lindner

23 papers receiving 376 citations

Peers

Kirsten Eibl‐Lindner
BE DAMATO United Kingdom
Matthew A. Cunningham United States
Anna M. Demetriades United States
Pooja D. Jani United States
Jingliang He China
Bonnie Archer United States
Miki Honda Japan
Tomoko Orita Japan
Tetsuya Toyono Japan
Ulrich Welge‐Luessen Germany
BE DAMATO United Kingdom
Kirsten Eibl‐Lindner
Citations per year, relative to Kirsten Eibl‐Lindner Kirsten Eibl‐Lindner (= 1×) peers BE DAMATO

Countries citing papers authored by Kirsten Eibl‐Lindner

Since Specialization
Citations

This map shows the geographic impact of Kirsten Eibl‐Lindner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten Eibl‐Lindner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten Eibl‐Lindner more than expected).

Fields of papers citing papers by Kirsten Eibl‐Lindner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten Eibl‐Lindner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten Eibl‐Lindner. The network helps show where Kirsten Eibl‐Lindner may publish in the future.

Co-authorship network of co-authors of Kirsten Eibl‐Lindner

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten Eibl‐Lindner. A scholar is included among the top collaborators of Kirsten Eibl‐Lindner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten Eibl‐Lindner. Kirsten Eibl‐Lindner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kassumeh, Stefan, Nikolaus Luft, Siegfried Priglinger, et al.. (2022). Pharmacological drug screening to inhibit uveal melanoma metastatic cells either via EGF-R, MAPK, mTOR or PI3K. International Journal of Ophthalmology. 15(10). 1569–1576. 4 indexed citations
2.
Masmoudi, Yasmine, et al.. (2020). Supercritical fluid technology for the development of innovative ophthalmic medical devices: Drug loaded intraocular lenses to mitigate posterior capsule opacification. European Journal of Pharmaceutics and Biopharmaceutics. 149. 248–256. 33 indexed citations
3.
Siedlecki, Jakob, Christian Wertheimer, Andreas Ohlmann, et al.. (2018). Combined VEGF/PDGF inhibition using axitinib induces αSMA expression and a pro-fibrotic phenotype in human pericytes. Graefe s Archive for Clinical and Experimental Ophthalmology. 256(6). 1141–1149. 14 indexed citations
4.
Wertheimer, Christian, Jakob Siedlecki, Christian Braun, et al.. (2018). The intraocular lens as a drug delivery device for an epidermal growth factor–Receptor inhibitor for prophylaxis of posterior capsule opacification. Acta Ophthalmologica. 96(7). e874–e882. 20 indexed citations
5.
Siedlecki, Jakob, Christian Wertheimer, Armin Wolf, et al.. (2017). Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro. Graefe s Archive for Clinical and Experimental Ophthalmology. 255(5). 963–972. 40 indexed citations
6.
Wertheimer, Christian, Kirsten Eibl‐Lindner, Armin Wolf, et al.. (2017). A cell culture technique for human epiretinal membranes to describe cell behavior and membrane contraction in vitro. Graefe s Archive for Clinical and Experimental Ophthalmology. 255(11). 2147–2155. 8 indexed citations
7.
Siedlecki, Jakob, Marc J. Mackert, Armin Wolf, et al.. (2017). BILATERAL VISUAL FIELD DEFECTS IN A PATIENT TREATED WITH THE MEK AND BRAF INHIBITORS TRAMETINIB AND DABRAFENIB FOR MELANOMA OF UNKNOWN ORIGIN. Retinal Cases & Brief Reports. 13(3). 215–219. 7 indexed citations
8.
Siedlecki, Jakob, Simon F. Leicht, Paul Foerster, et al.. (2017). Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy. Acta Ophthalmologica. 95(8). e734–e739. 18 indexed citations
9.
Wertheimer, Christian, Stefan Kassumeh, Christian Braun, et al.. (2017). The Intraocular Lens as a Drug Delivery Device: In Vitro Screening of Pharmacologic Substances for the Prophylaxis of Posterior Capsule Opacification. Investigative Ophthalmology & Visual Science. 58(14). 6408–6408. 30 indexed citations
10.
Eibl‐Lindner, Kirsten, Christoph Fürweger, Martin M. Nentwich, et al.. (2015). Robotic radiosurgery for the treatment of medium and large uveal melanoma. Melanoma Research. 26(1). 51–57. 44 indexed citations
11.
Wertheimer, Christian, Daniel Kook, Wolfgang J. Mayer, et al.. (2015). Erufosine, a phosphoinositide-3-kinase inhibitor, to mitigate posterior capsule opacification in the human capsular bag model. Journal of Cataract & Refractive Surgery. 41(7). 1484–1489. 12 indexed citations
12.
Wertheimer, Christian, Jakob Siedlecki, Daniel Kook, et al.. (2014). EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model. Graefe s Archive for Clinical and Experimental Ophthalmology. 253(3). 409–417. 26 indexed citations
13.
Wertheimer, Christian, Raffael Liegl, Marcus Kernt, et al.. (2014). EGFR-Blockade With Erlotinib Reduces EGF and TGF-β2 Expression and the Actin-Cytoskeleton Which Influences Different Aspects of Cellular Migration in Lens Epithelial cells. Current Eye Research. 39(10). 1000–1012. 22 indexed citations
14.
Leicht, Simon F., Christian Wertheimer, Raffael Liegl, Anselm Kampik, & Kirsten Eibl‐Lindner. (2013). Vemurafenib as a therapeutic option for treatment of melanoma. Investigative Ophthalmology & Visual Science. 54(15). 4208–4208. 1 indexed citations
15.
Eibl‐Lindner, Kirsten, Raffael Liegl, Christian Wertheimer, & Anselm Kampik. (2013). Intraokularlinse als Medikamententräger. Der Ophthalmologe. 110(10). 990–994. 6 indexed citations
16.
Liegl, Raffael, Christian Wertheimer, Marcus Kernt, et al.. (2013). Attenuation of human lens epithelial cell spreading, migration and contraction via downregulation of the PI3K/Akt pathway. Graefe s Archive for Clinical and Experimental Ophthalmology. 252(2). 285–292. 15 indexed citations
17.
Wertheimer, Christian, Raffael Liegl, Marcus Kernt, et al.. (2013). EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification. Graefe s Archive for Clinical and Experimental Ophthalmology. 251(6). 1529–1540. 22 indexed citations
18.
Wörnle, Markus, Monika Merkle, Armin Wolf, et al.. (2011). Inhibition of TLR3-Mediated Proinflammatory Effects by Alkylphosphocholines in Human Retinal Pigment Epithelial Cells. Investigative Ophthalmology & Visual Science. 52(9). 6536–6536. 20 indexed citations
19.
Liegl, Raffael, Marcus Kernt, Armin Wolf, et al.. (2010). Alkylphosphocholine hemmen die Proliferation und Anhaftung von Linsenepithelzellen. Der Ophthalmologe. 107(10). 937–940. 2 indexed citations
20.
Lüke, Matthias, Kai Januschowski, Julia Lüke, et al.. (2009). The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina. Graefe s Archive for Clinical and Experimental Ophthalmology. 248(4). 511–518. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by BE DAMATO Breakdown of academic impact, for papers by Matthew A. Cunningham Breakdown of academic impact, for papers by Anna M. Demetriades Breakdown of academic impact, for papers by Pooja D. Jani Breakdown of academic impact, for papers by Jingliang He Breakdown of academic impact, for papers by Bonnie Archer Breakdown of academic impact, for papers by Miki Honda Breakdown of academic impact, for papers by Tomoko Orita Breakdown of academic impact, for papers by Tetsuya Toyono Breakdown of academic impact, for papers by Ulrich Welge‐Luessen
Rankless by CCL
2026